A rarer pathophysiological mechanism of AE is bradykinin-mediated angioedema (AE-BK), which results from excessive bradykinin production due to dysregulation of the contact pathway, or decreased catabolism, such as in ACE inhibitor-induced AE, leading to edema. The gene discussed is ACE; the disease is angioedema.